Keyword: generic drugs

News

New EU Generics Rules to Boost Competitiveness

26.02.2019 - The EU is adopting new rules that should make it easier for producers of generic drugs and biosimilars in member states to compete on the global market. On Feb. 20, the states...

News

Pfizer Sells Stake in Chinese JV with Hisun

15.11.2017 - US pharmaceutical giant Pfizer has divested its 49% stake in Hisun-Pfizer Pharmaceuticals its Chinese joint venture with Zhejiang Hisun Pharma. As part of the plan, Sapphire I...

News

US Generics Price Probe Nearing Climax?

15.11.2016 - The US Department of Justice (DOJ) is stepping up its broad criminal investigation into suspected price fixing for generic drugs. A Grand Jury probe in the two-year-old case is...

News

Teva says Actavis Closing on Track

11.05.2016 - Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...

News

High Drug Prices Said “Infecting” Generics

28.01.2016 - The pharmaceutical industry has often been accused of trying to keep affordable generic drugs off the market, with the addition – for example – of new indications or product...

News

Imprimis Touts Cheaper Daraprim Alternative

26.10.2015 - California-based Imprimis Pharmaceuticals is touting a customizable compounded formulation of pyrimethamine and leucovorin as a low cost alternative to Daraprim, the drug that made...

Plant Construction & Process Technology

Innovative Medicine with Rising Productivity Targets

07.10.2015 - The need to get products quicker to market, to ensure greater regulatory compliance and to boost efficiencies while reducing operational cost is a challenging goal. Owing to the...

Plant Construction & Process Technology

The Biggest Side-Effect of Making Medicine

07.10.2015 - International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the...